Underage youth and young adult e-cigarette use and access before and during the coronavirus disease 2019 pandemic SM Gaiha, LK Lempert, B Halpern-Felsher JAMA network open 3 (12), e2027572-e2027572, 2020 | 182 | 2020 |
Packaging colour research by tobacco companies: the pack as a product characteristic LK Lempert, S Glantz Tobacco control 26 (3), 307-315, 2017 | 99 | 2017 |
The importance of product definitions in US e-cigarette laws and regulations LK Lempert, R Grana, SA Glantz Tobacco Control 25 (e1), e44-e51, 2016 | 71 | 2016 |
Light and mild redux: heated tobacco products’ reduced exposure claims are likely to be misunderstood as reduced risk claims L Popova, LK Lempert, SA Glantz Tobacco control 27 (Suppl 1), s87-s95, 2018 | 65 | 2018 |
IQOS labelling will mislead consumers K McKelvey, L Popova, M Kim, LK Lempert, BW Chaffee, ... Tobacco control 27 (Suppl 1), s48-s54, 2018 | 57 | 2018 |
Tobacco industry promotional strategies targeting American Indians/Alaska natives and exploiting tribal sovereignty LK Lempert, SA Glantz Nicotine and Tobacco Research 21 (7), 940-948, 2019 | 49 | 2019 |
E-cigarette devices, brands, and flavors attract youth: informing FDA's policies and priorities to close critical gaps SM Gaiha, LK Lempert, K McKelvey, B Halpern-Felsher Addictive behaviors 126, 107179, 2022 | 46 | 2022 |
Heated tobacco product regulation under US law and the FCTC LK Lempert, SA Glantz Tobacco control 27 (Suppl 1), s118-s125, 2018 | 41 | 2018 |
Implications of tobacco industry research on packaging colors for designing health warning labels LK Lempert, SA Glantz Nicotine & Tobacco Research 18 (9), 1910-1914, 2016 | 36 | 2016 |
Analysis of FDA’s IQOS marketing authorisation and its policy impacts LK Lempert, S Glantz Tobacco control 30 (4), 413-421, 2021 | 33 | 2021 |
Use, marketing, and appeal of oral nicotine products among adolescents, young adults, and adults SM Gaiha, C Lin, LK Lempert, B Halpern-Felsher Addictive Behaviors 140, 107632, 2023 | 21 | 2023 |
Adolescents, young adults, and adults continue to use e-cigarette devices and flavors two years after FDA discretionary enforcement DM McCauley, SM Gaiha, LK Lempert, B Halpern-Felsher International journal of environmental research and public health 19 (14), 8747, 2022 | 20 | 2022 |
Use patterns, flavors, brands, and ingredients of nonnicotine e-cigarettes among adolescents, young adults, and adults in the United States SM Gaiha, C Lin, LK Lempert, B Halpern-Felsher JAMA Network Open 5 (5), e2216194-e2216194, 2022 | 20 | 2022 |
Flavored tobacco sales restrictions reduce tobacco product availability and retailer advertising LM Holmes, LK Lempert, PM Ling International journal of environmental research and public health 19 (6), 3455, 2022 | 16 | 2022 |
FDA’s reduced exposure marketing order for IQOS: why it is not a reliable global model LK Lempert, S Bialous, S Glantz Tobacco control 31 (e1), e83-e87, 2022 | 13 | 2022 |
Underage youth and young adult e-cigarette use and access before and during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020; 3 (12): e2027572 SM Gaiha, LK Lempert, B Halpern-Felsher | 11 | 2020 |
Substantial equivalence standards in tobacco governance: Statutory clarity and regulatory precedent for the FSPTCA D Carpenter, GN Connolly, LK Lempert Journal of Health Politics, Policy and Law 42 (4), 607-644, 2017 | 8 | 2017 |
Cigarette company trade secrets are not secret: an analysis of reverse engineering reports in internal tobacco industry documents released as a result of litigation C Velicer, LK Lempert, S Glantz Tobacco control 24 (5), 469-480, 2015 | 8 | 2015 |
Underage youth and young adult e-cigarette use and access before and during the Coronavirus Disease 2019 pandemic. JAMA Network Open, 3 (12), e2027572 SM Gaiha, LK Lempert, B Halpern-Felsher | 6 | 2020 |
Emerging indoor air laws for onsite cannabis consumption businesses in the US TL Rotering, LK Lempert, SA Glantz American Journal of Preventive Medicine 61 (6), e267-e278, 2021 | 5 | 2021 |